This is a routine annual filing with no significant changes to governance or strategy. Monitor for any shareholder proposals or voting results from the meeting, but no immediate trading action is warranted.
Price Chart
Executive Summary
Tenax Therapeutics filed its definitive proxy statement (DEFA14A) for its 2026 annual meeting, which includes the re-election of all seven current directors and the ratification of Cherry Bekaert LLP as the independent auditor. This filing follows the recent appointment of Thomas Staab as CFO, indicating management continuity.
Key Financial Metrics
Key Facts
- Proxy statement filed for the 2026 Annual Meeting on June 2, 2026.
- Seven director nominees are up for re-election.
- Ratification of Cherry Bekaert LLP as the independent auditor is proposed.
- Follows the recent appointment of Thomas Staab as CFO.
Financial Impact
No immediate financial impact.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-168682 |
| Document: 0001193125-26-168682-index-headers.html | 0001193125-26-168682 |
| Document: 0001193125-26-168682-index.html | 0001193125-26-168682 |
| Document: 0001193125-26-168682.txt | 0001193125-26-168682 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | SC 13G/A | $1.36 $1.72 | ▲ +26.47% | ▲ +26.90% | $1.75 (+28.31%) |
Oct 13, 2026 14d ago | SC 13G/A | $1.60 $1.63 | ▲ +1.88% | ▲ +3.03% | $1.75 (+9.06%) |
Oct 9, 2026 17d ago | SC 13G/A | $1.83 $1.52 | ▼ −16.94% | ▼ −15.45% | $1.75 (−4.64%) |
Oct 8, 2026 18d ago | 8-K | $1.87 $1.36 | ▼ −27.27% | ▼ −25.30% | $1.75 (−6.68%) |
Sep 17, 2026 5w ago | Insider Cluster | $1.90 $1.81 | ▼ −4.74% | ▼ −6.01% | $1.75 (−8.16%) |
Sep 9, 2026 6w ago | 8-K | $2.13 $1.82 | ▼ −14.55% | ▼ −13.90% | $1.75 (−18.08%) |
Aug 29, 2026 8w ago | Press Release | $1.84 $2.05 | ▲ +11.20% | ▲ +11.34% | $1.75 (−5.16%) |
Aug 10, 2026 11w ago | 8-K | $1.38 $1.71 | ▲ +24.36% | ▲ +24.41% | $1.75 (+26.91%) |
Aug 10, 2026 11w ago | Press Release | $1.38 $1.71 | ▲ +24.36% | ▲ +24.41% | $1.75 (+26.91%) |
Jul 31, 2026 12w ago | 8-K | $13.70 $13.44 | ▼ −1.90% | ▼ −5.41% | $1.75 (−87.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers